Home
About/Contact
Newsletters
Events/Seminars
2020 IPS Conference
Study Materials
Corporate Members
Status Report on the SARAF Accelerator Project Phase I
Amichay Perry [1] , Dan Berkovits [1] , Ilan Eliyahu [1] , Isaac Gertz [1] , Asher Grin [1] , Shlomi Halfon [1] , Geoff Lempert [1] , Israel Mardor [1] , Ami Nagler [1] , Jacob Rodnizki [1] , Leonid Weissman [1] , Kai Dunkel [2] , Michael Pekeler [2] , Chirstian Piel [2] , Peter vom Stein [2] , Alexander Bechtold [3]
[1] Soreq Nuclear Research Center, Yavne
[2] RI Research Instruments GmbH, Germany
[3] NTG, Gelnhausen, Germany
The Soreq Applied Research Accelerator Facility, SARAF, is currently under construction at Soreq NRC. SARAF will be a multi-user facility for basic, medical and biological research, non-destructive testing (NDT) and research, development and production of radio-isotopes for pharmaceutical purposes. SARAF is based on a continuous wave (cw), proton/deuteron RF superconducting linear accelerator with variable energy (5-40 MeV) and current (0.04-2 mA). Phase I of SARAF has been installed and is currently being commissioned at Soreq NRC. According to the Phase I design, SARAF should yield 2 mA proton and deuteron beams at energies up to 4 and 5 MeV, respectively. The status of the main Phase I components is reported. We further present beam commissioning results, which include acceleration of a 1 mA CW proton beam up to 3 MeV. Further improvements in the facility in order to achieve the desired performance are discussed.